These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. A prospective case study of high boost, high frequency emphasis and two-way diffusion filters on MR images of glioblastoma multiforme. Anoop BN; Joseph J; Williams J; Jayaraman JS; Sebastian AM; Sihota P Australas Phys Eng Sci Med; 2018 Jun; 41(2):415-427. PubMed ID: 29654522 [TBL] [Abstract][Full Text] [Related]
25. Novel Radiomic Features Based on Joint Intensity Matrices for Predicting Glioblastoma Patient Survival Time. Chaddad A; Daniel P; Desrosiers C; Toews M; Abdulkarim B IEEE J Biomed Health Inform; 2019 Mar; 23(2):795-804. PubMed ID: 29993848 [TBL] [Abstract][Full Text] [Related]
26. Glioblastoma multiforme: radiologic-pathologic correlation. Rees JH; Smirniotopoulos JG; Jones RV; Wong K Radiographics; 1996 Nov; 16(6):1413-38; quiz 1462-3. PubMed ID: 8946545 [TBL] [Abstract][Full Text] [Related]
28. Volumetric assessment of glioblastoma and its predictive value for survival. Henker C; Hiepel MC; Kriesen T; Scherer M; Glass Ä; Herold-Mende C; Bendszus M; Langner S; Weber MA; Schneider B; Unterberg A; Piek J Acta Neurochir (Wien); 2019 Aug; 161(8):1723-1732. PubMed ID: 31254065 [TBL] [Abstract][Full Text] [Related]
29. Prediction of survival with multi-scale radiomic analysis in glioblastoma patients. Chaddad A; Sabri S; Niazi T; Abdulkarim B Med Biol Eng Comput; 2018 Dec; 56(12):2287-2300. PubMed ID: 29915951 [TBL] [Abstract][Full Text] [Related]
30. Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging. Kim R; Choi SH; Yun TJ; Lee ST; Park CK; Kim TM; Kim JH; Park SW; Sohn CH; Park SH; Kim IH Eur Radiol; 2017 Mar; 27(3):1176-1185. PubMed ID: 27357131 [TBL] [Abstract][Full Text] [Related]
31. Effect of fractal-shaped outer boundary of glioblastoma multiforme on drug delivery. Samioti SE; Benos LT; Sarris IE Comput Methods Programs Biomed; 2019 Sep; 178():191-199. PubMed ID: 31416549 [TBL] [Abstract][Full Text] [Related]
32. Predicting Glioblastoma Recurrence by Early Changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images. Chang PD; Chow DS; Yang PH; Filippi CG; Lignelli A AJR Am J Roentgenol; 2017 Jan; 208(1):57-65. PubMed ID: 27726412 [TBL] [Abstract][Full Text] [Related]
33. A quantitative study of shape descriptors from glioblastoma multiforme phenotypes for predicting survival outcome. Chaddad A; Desrosiers C; Hassan L; Tanougast C Br J Radiol; 2016 Dec; 89(1068):20160575. PubMed ID: 27781499 [TBL] [Abstract][Full Text] [Related]
34. Association of Radiomics and Metabolic Tumor Volumes in Radiation Treatment of Glioblastoma Multiforme. Lopez CJ; Nagornaya N; Parra NA; Kwon D; Ishkanian F; Markoe AM; Maudsley A; Stoyanova R Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):586-595. PubMed ID: 28011044 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of subventricular zone involvement in relation to tumor volumes defined by fused MRI and O-(2-[ Harat M; Małkowski B; Roszkowski K Radiat Oncol; 2019 Mar; 14(1):37. PubMed ID: 30832691 [TBL] [Abstract][Full Text] [Related]
36. Radiological features of infantile glioblastoma and desmoplastic infantile tumors: British Columbia's Children's Hospital experience. Bader A; Heran M; Dunham C; Steinbok P J Neurosurg Pediatr; 2015 Aug; 16(2):119-25. PubMed ID: 25955808 [TBL] [Abstract][Full Text] [Related]
37. The Monocarboxylate transporter inhibitor Quercetin induces intracellular acidification in a mouse model of Glioblastoma Multiforme: in-vivo detection using magnetic resonance imaging. Albatany M; Meakin S; Bartha R Invest New Drugs; 2019 Aug; 37(4):595-601. PubMed ID: 30101388 [TBL] [Abstract][Full Text] [Related]
38. Does Pretreatment Tumor Growth Hold Prognostic Information for Patients with Glioblastoma? Stensjøen AL; Berntsen EM; Mikkelsen VE; Torp SH; Jakola AS; Salvesen Ø; Solheim O World Neurosurg; 2017 May; 101():686-694.e4. PubMed ID: 28300718 [TBL] [Abstract][Full Text] [Related]
39. Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients. Molina D; Pérez-Beteta J; Martínez-González A; Sepúlveda JM; Peralta S; Gil-Gil MJ; Reynes G; Herrero A; De Las Peñas R; Luque R; Capellades J; Balaña C; Pérez-García VM PLoS One; 2016; 11(8):e0161484. PubMed ID: 27557121 [TBL] [Abstract][Full Text] [Related]
40. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach. Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]